Clinical evaluation and power Doppler sonography in rheumatoid arthritis: Evidence for ongoing synovial inflammation in clinical remission

被引:45
作者
Ozgocmen, Salih [1 ]
Ozdemir, Huseyin
Kiris, Adem
Bozgeyik, Zulkif
Ardicoglu, Ozge
机构
[1] Firat Univ, Tip Fak, Div Rheumatol, Dept PMR,Fiziksel Tip Rehabil AD,Romatol BD, TR-23119 Elazig, Turkey
关键词
disease activity; power doppler; rheumatoid arthritis; spectral Doppler;
D O I
10.1097/SMJ.0b013e318164e16a
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: This study proposed to assess the relationship between power Doppler ultrasound examination and spectral Doppler analysis of hand joints with clinical and laboratory parameters in rheumatoid arthritis. Methods: Patients receiving disease-modifying antirheumatic drugs or biologics (infliximab) underwent joint examination and were assessed by a Health Assessment Questionnaire, Duruoz's Hand Index, and Hand Function Test. All were categorized for disease activity using the American College of Rheumatology and disease activity score 28-joint (DAS28) criteria. Ten metacarpophalangeal joints and 4 wrist joints (ulnar-carpal and radiocarpal joints) in each patient were examined by power Doppler and spectral Doppler. Flow signal in the synovium was semiquantitatively graded. A cumulative flow signal score (CFS) and mean resistive index (RI) was calculated in each patient. Results: Patients with active disease had significantly higher CFS compared with patients with inactive disease, but the mean PI was similar. Health Assessment Questionnaire, Duruoz's Hand Index, Larsen, and DAS28 scores correlated significantly with CFS, but the erythrocyte sedimentation rate and C-reactive protein scores did not. Mean RI did not correlate with clinical or laboratory parameters. A majority of patients who were in clinical remission according to American College of Rheumatology or DAS28 criteria had ongoing synovial inflammation on power Doppler ultrasound (58% and 62%, respectively). Conclusion: Power Doppler examination of rheumatoid hand joints is a practical method to estimate synovial inflammation. A modification of current remission criteria by combining imaging techniques with clinical and laboratory examination may be conceivable. These results underscore the necessity of more sophisticated research, assessing the agreement between long-term Doppler changes and clinical parameters.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 38 条
[1]
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[2]
Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO
[3]
2-3
[4]
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression [J].
Brown, A. K. ;
Quinn, M. A. ;
Karim, Z. ;
Conaghan, P. G. ;
Peterfy, C. G. ;
Hensor, E. ;
Wakefield, R. J. ;
O'Connor, P. J. ;
Emery, P. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3761-3773
[5]
Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience [J].
Carotti, M ;
Salaffi, F ;
Manganelli, P ;
Salera, D ;
Simonetti, B ;
Grassi, W .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :877-882
[6]
Duruoz MT, 1996, J RHEUMATOL, V23, P1167
[7]
THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
CHERNOFF, M ;
FRIED, B ;
FURST, D ;
GOLDSMITH, C ;
KIESZAK, S ;
LIGHTFOOT, R ;
PAULUS, H ;
TUGWELL, P ;
WEINBLATT, M ;
WIDMARK, R ;
WILLIAMS, HJ ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :729-740
[8]
Firestein G., 2001, ETIOLOGY PATHOGENESI
[9]
SOFT-TISSUE CHANGES IN THE HAND IN RHEUMATOID-ARTHRITIS - EVALUATION WITH ULTRASONOGRAPHY [J].
FORNAGE, BD .
RADIOLOGY, 1989, 173 (03) :735-737
[10]
High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor α receptor (etanercept) [J].
Hau, M ;
Kneitz, C ;
Tony, HP ;
Keberle, M ;
Jahns, R ;
Jenett, M .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (01) :55-58